U.S. market Closed. Opens in 11 hours 48 minutes

APRE | Aprea Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue583.23KN/AN/AN/AN/AN/AN/A
Cost of Revenue7.05K186.44K271.68K229.61K170.25KN/AN/A
Gross Profit576.18K-186.44K-271.68K-229.61K-170.25KN/AN/A
Operating Expenses16.05M37.37M37.45M52.81M29.54M16.49M15.85M
Selling, General & Admin8.42M20.97M13.55M14.93M8.59M2.29M2.46M
Research & Development7.63M16.40M23.90M37.88M20.95M14.19M13.39M
Other Operating ExpensesN/A76.02MN/AN/AN/AN/AN/A
Operating Income-15.47M38.18M-38.04M-52.15M-31.04M-16.49M-15.85M
Other Expenses / Income1.19M-150.84M908.13K-1.33M2.98M961.32K662.12K
Before Tax Income-14.29M-112.66M-37.13M-53.48M-28.06M-15.53M-15.19M
Income Tax Expenses-2.00112.21M-590.73K437.99K-1.65M961.32KN/A
Net Income-14.29M-224.88M-36.54M-53.92M-26.41M-15.53M-15.19M
Interest ExpensesN/A448.67KN/A222.65K156.35K182.0015.00
Basic Shares Outstanding3.62M82.85K1.06M1.06M300.12K703.78K703.78K
Diluted Shares Outstanding3.62M82.85K1.06M1.06M300.12K703.78K703.78K
EBITDA-15.46M38.37M-37.76M-51.92M-30.87M-16.48M-15.18M
EBITDA Margin-2,651.59%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-14.29M-112.21M-37.13M-53.26M-27.90M-14.57M-15.19M
EBIT Margin-2,449.59%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙